Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study

María Dolores Martín Arranz,Laura García-Ramírez,Eduardo Martín Arranz,Dolores Montero Vega,José Luis Rueda García,María Sánchez-Azofra,Joaquín Poza Cordón,Jesús Noci Belda,Tamara Verges Martínez-Meco,Paula Blanco San Miguel,Cristina Suárez-Ferrer

Revista Española de Enfermedades Digestivas（2022）

引用 2|浏览11

暂无评分

摘要

the antibody response after vaccination against SARS-CoV-2 is high in patients with inflammatory bowel disease. However, patients treated with immunosuppressive or biologic drugs had a lower response. Adverse events were frequent, but not serious.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要